| 1 | Opposing roles for <scp>ADAMTS2</scp> and <scp>ADAMTS14</scp> in myofibroblast differentiation and function | 5.0 | 7 | Citations (PDF) |
| 2 | ALK1 controls hepatic vessel formation, angiodiversity, and angiocrine functions in hereditary hemorrhagic telangiectasia of the liver | 10.6 | 30 | Citations (PDF) |
| 3 | <scp>ST3GAL5</scp>‐catalyzed gangliosides inhibit <scp>TGF</scp>‐β‐induced epithelial‐mesenchymal transition via <scp>TβRI</scp> degradation | 7.4 | 34 | Citations (PDF) |
| 4 | Opposing USP19 splice variants in TGF-β signaling and TGF-β-induced epithelial–mesenchymal transition of breast cancer cells | 5.6 | 14 | Citations (PDF) |
| 5 | Combination of photodynamic therapy and stimulator of interferon genes (STING) agonist inhibits colorectal tumor growth and recurrence | 12.0 | 15 | Citations (PDF) |
| 6 | Intertumoral Differences Dictate the Outcome of TGF-β Blockade on the Efficacy of Viro-Immunotherapy | 2.9 | 8 | Citations (PDF) |
| 7 | Differential optineurin expression controls <scp>TGFβ</scp> signaling and is a key determinant for metastasis of triple negative breast cancer | 4.5 | 8 | Citations (PDF) |
| 8 | LncRNA LITATS1 suppresses TGF‐β‐induced EMT and cancer cell plasticity by potentiating TβRI degradation | 7.4 | 61 | Citations (PDF) |
| 9 | The lncRNA LETS1 promotes TGF-β–induced EMT and cancer cell migration by transcriptionally activating a TβR1-stabilizing mechanism | 5.5 | 22 | Citations (PDF) |
| 10 | TGF-β Type I Receptor Signaling in Melanoma Liver Metastases Increases Metastatic Outgrowth | 4.5 | 3 | Citations (PDF) |
| 11 | Genome-wide CRISPR screens define determinants of epithelial-mesenchymal transition mediated immune evasion by pancreatic cancer cells | 11.0 | 19 | Citations (PDF) |
| 12 | CD44 acts as a coreceptor for cell-specific enhancement of signaling and regulatory T cell induction by TGM1, a parasite TGF-β mimic | 7.6 | 22 | Citations (PDF) |
| 13 | The protein kinase LKB1 promotes self‐renewal and blocks invasiveness in glioblastoma | 4.2 | 11 | Citations (PDF) |
| 14 | Follistatin‐controlled activin‐HNF4α‐coagulation factor axis in liver progenitor cells determines outcome of acute liver failure | 10.6 | 25 | Citations (PDF) |
| 15 | Combinatorial Therapeutic Approaches with Nanomaterial-Based Photodynamic Cancer Therapy | 5.1 | 51 | Citations (PDF) |
| 16 | RNF12 is regulated by AKT phosphorylation and promotes TGF-β driven breast cancer metastasis | 8.7 | 18 | Citations (PDF) |
| 17 | Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage nichesCell, 2022, 185, 379-396.e38 | 34.1 | 799 | Citations (PDF) |
| 18 | CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumors 2022, 10, e003995 | | 30 | Citations (PDF) |
| 19 | Transforming growth factor-β challenge alters the N-, O-, and glycosphingolipid glycomes in PaTu-S pancreatic adenocarcinoma cells | 2.2 | 8 | Citations (PDF) |
| 20 | TGFβ selects for pro‐stemness over pro‐invasive phenotypes during cancer cell epithelial–mesenchymal transition | 4.2 | 13 | Citations (PDF) |
| 21 | A Programmable Multifunctional 3D Cancer Cell Invasion Micro Platform | 11.6 | 9 | Citations (PDF) |
| 22 | Crystal structures of BMPRII extracellular domain in binary and ternary receptor complexes with BMP10 | 13.9 | 16 | Citations (PDF) |
| 23 | Microfluidics meets 3D cancer cell migration | 10.6 | 61 | Citations (PDF) |
| 24 | OVOL1 inhibits breast cancer cell invasion by enhancing the degradation of TGF-β type I receptor | 43.9 | 36 | Citations (PDF) |
| 25 | Dynamic Visualization of TGF-β/SMAD3 Transcriptional Responses in Single Living Cells | 4.0 | 16 | Citations (PDF) |
| 26 | Photodynamic Therapy in Combination with the Hepatitis B Core Virus-like Particles (HBc VLPs) to Prime Anticancer Immunity for Colorectal Cancer Treatment | 4.0 | 18 | Citations (PDF) |
| 27 | Synthesis and preclinical evaluation of [11C]LR111 and [18F]EW-7197 as PET tracers of the activin-receptor like kinase-5 | 0.3 | 1 | Citations (PDF) |
| 28 | Low Transforming Growth Factor-β Pathway Activity in Cervical Adenocarcinomas | 2.7 | 5 | Citations (PDF) |
| 29 | TRAF4 Inhibits Bladder Cancer Progression by Promoting BMP/SMAD Signaling | 3.2 | 20 | Citations (PDF) |
| 30 | <scp>USP8</scp> promotes cancer progression and extracellular vesicle‐mediated <scp>CD8</scp>+ T cell exhaustion by deubiquitinating the <scp>TGF</scp>‐β receptor <scp>TβRII</scp> | 7.4 | 77 | Citations (PDF) |
| 31 | E3 Ubiquitin Ligases: Key Regulators of TGFβ Signaling in Cancer Progression | 4.5 | 25 | Citations (PDF) |
| 32 | A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis | 8.2 | 22 | Citations (PDF) |
| 33 | Targeting TGFβ signal transduction for cancer therapy | 43.9 | 346 | Citations (PDF) |
| 34 | TGF-&#946;-mediated Endothelial to Mesenchymal Transition (EndMT) and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing | 0.3 | 9 | Citations (PDF) |
| 35 | TGF-β-Induced Endothelial to Mesenchymal Transition Is Determined by a Balance Between SNAIL and ID Factors | 3.7 | 42 | Citations (PDF) |
| 36 | Challenges and Opportunities for Drug Repositioning in Fibrodysplasia Ossificans Progressiva | 3.5 | 13 | Citations (PDF) |
| 37 | Endothelium-derived stromal cells contribute to hematopoietic bone marrow niche formation | 16.8 | 51 | Citations (PDF) |
| 38 | Inhibiting Endothelial Cell Function in Normal and Tumor Angiogenesis Using BMP Type I Receptor Macrocyclic Kinase Inhibitors | 4.0 | 6 | Citations (PDF) |
| 39 | Inhibition of the prolyl isomerase Pin1 improves endothelial function and attenuates vascular remodelling in pulmonary hypertension by inhibiting TGF-β signalling | 7.9 | 16 | Citations (PDF) |
| 40 | Cripto favors chondrocyte hypertrophy via <scp>TGF</scp>‐β <scp>SMAD1</scp>/5 signaling during development of osteoarthritis | 5.0 | 17 | Citations (PDF) |
| 41 | Metabolic Reprogramming of Mammary Epithelial Cells during TGF-β-Induced Epithelial-to-Mesenchymal Transition | 3.5 | 15 | Citations (PDF) |
| 42 | Therapeutic targeting of TGF-β in cancer: hacking a master switch of immune suppression | 6.4 | 66 | Citations (PDF) |
| 43 | The polarity protein Par3 coordinates positively self-renewal and negatively invasiveness in glioblastoma | 8.7 | 6 | Citations (PDF) |
| 44 | Breast cancer dormancy is associated with a 4NG1 state and not senescence | 6.5 | 20 | Citations (PDF) |
| 45 | Cancer associated-fibroblast-derived exosomes in cancer progression | 32.3 | 285 | Citations (PDF) |
| 46 | VprBP mitigates TGF-β and Activin signaling by promoting Smurf1-mediated type I receptor degradation | 3.6 | 15 | Citations (PDF) |
| 47 | THG-1 suppresses SALL4 degradation to induce stemness genes and tumorsphere formation through antagonizing NRBP1 in squamous cell carcinoma cells | 2.1 | 14 | Citations (PDF) |
| 48 | Deubiquitinase Activity Profiling Identifies UCHL1 as a Candidate Oncoprotein That Promotes TGFβ-Induced Breast Cancer Metastasis | 6.9 | 124 | Citations (PDF) |
| 49 | Current perspectives on inhibitory SMAD7 in health and disease | 6.8 | 68 | Citations (PDF) |
| 50 | TGF‐β signaling in liver metastasis | 5.7 | 48 | Citations (PDF) |
| 51 | Reactivation of BMP signaling by suboptimal concentrations of MEK inhibitor and FK506 reduces organ-specific breast cancer metastasis | 8.8 | 24 | Citations (PDF) |
| 52 | Mechanotransduction is a context-dependent activator of TGF-β signaling in mesenchymal stem cells | 12.3 | 41 | Citations (PDF) |
| 53 | Small-Molecule Activity-Based Probe for Monitoring Ubiquitin C-Terminal Hydrolase L1 (UCHL1) Activity in Live Cells and Zebrafish Embryos | 15.0 | 71 | Citations (PDF) |
| 54 | Cercosporamide inhibits bone morphogenetic protein receptor type I kinase activity in zebrafish | 2.0 | 9 | Citations (PDF) |
| 55 | TGF-β-Induced Endothelial to Mesenchymal Transition in Disease and Tissue Engineering | 3.7 | 211 | Citations (PDF) |
| 56 | Secreted BMP antagonists and their role in cancer and bone metastases | 3.6 | 28 | Citations (PDF) |
| 57 | MnTBAP Reverses Pulmonary Vascular Remodeling and Improves Cardiac Function in Experimentally Induced Pulmonary Arterial Hypertension | 4.5 | 5 | Citations (PDF) |
| 58 | Bone morphogenetic protein receptors: Structure, function and targeting by selective small molecule kinase inhibitors | 3.6 | 107 | Citations (PDF) |
| 59 | Differential O- and Glycosphingolipid Glycosylation in Human Pancreatic Adenocarcinoma Cells With Opposite Morphology and Metastatic Behavior | 2.7 | 24 | Citations (PDF) |
| 60 | A Signaling Crosstalk between BMP9 and HGF/c-Met Regulates Mouse Adult Liver Progenitor Cell Survival | 4.8 | 13 | Citations (PDF) |
| 61 | Immunotherapeutic Potential of TGF-β Inhibition and Oncolytic Viruses | 10.6 | 63 | Citations (PDF) |
| 62 | Mutant ACVR1 Arrests Glial Cell Differentiation to Drive Tumorigenesis in Pediatric Gliomas | 38.5 | 79 | Citations (PDF) |
| 63 | On-Target Anti-TGF-β Therapies Are Not Succeeding in Clinical Cancer Treatments: What Are Remaining Challenges? | 3.7 | 183 | Citations (PDF) |
| 64 | TGFβ and EGF signaling orchestrates the AP-1- and p63 transcriptional regulation of breast cancer invasiveness | 6.7 | 83 | Citations (PDF) |
| 65 | Tacrolimus-Induced BMP/SMAD Signaling Associates With Metabolic Stress–Activated FOXO1 to Trigger β-Cell Failure | 4.4 | 30 | Citations (PDF) |
| 66 | Development of a 96-well plate sample preparation method for integrated<i>N</i>- and<i>O</i>-glycomics using porous graphitized carbon liquid chromatography-mass spectrometry | 2.4 | 64 | Citations (PDF) |
| 67 | Role of glycosylation in TGF-β signaling and epithelial-to-mesenchymal transition in cancer | 3.6 | 66 | Citations (PDF) |
| 68 | Designed nanomolar small-molecule inhibitors of Ena/VASP EVH1 interaction impair invasion and extravasation of breast cancer cells | 7.6 | 34 | Citations (PDF) |
| 69 | Studying TGF-&#946; Signaling and TGF-&#946;-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells | 0.3 | 15 | Citations (PDF) |
| 70 | Uncovering the deubiquitinase activity landscape of breast cancer | 1.3 | 2 | Citations (PDF) |
| 71 | Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension | 5.0 | 45 | Citations (PDF) |
| 72 | Prevention of progression of pulmonary hypertension by the Nur77 agonist 6-mercaptopurine: role of BMP signalling | 12.1 | 33 | Citations (PDF) |
| 73 | In vivo imaging of TGFβ signalling components using positron emission tomography | 6.8 | 8 | Citations (PDF) |
| 74 | GREM1 is associated with metastasis and predicts poor prognosis in ER-negative breast cancer patients | 8.1 | 44 | Citations (PDF) |
| 75 | Generation of Fibrodysplasia ossificans progressiva and control integration free iPSC lines from periodontal ligament fibroblasts | 0.6 | 8 | Citations (PDF) |
| 76 | Development of Macrocycle Kinase Inhibitors for ALK2 Using Fibrodysplasia Ossificans Progressiva‐Derived Endothelial Cells | 2.1 | 37 | Citations (PDF) |
| 77 | Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression | 4.9 | 144 | Citations (PDF) |
| 78 | c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression | 13.9 | 57 | Citations (PDF) |
| 79 | Role of soluble endoglin in BMP9 signaling | 7.6 | 75 | Citations (PDF) |
| 80 | Generation of non-standard macrocyclic peptides specifically binding TSC-22 homologous gene-1 | 2.1 | 5 | Citations (PDF) |
| 81 | Epigenetic Reprogramming of TGF-β Signaling in Breast Cancer | 4.0 | 65 | Citations (PDF) |
| 82 | TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis | 4.5 | 984 | Citations (PDF) |
| 83 | DIPG-13. A NOVEL MOUSE MODEL REVEALS UNEXPECTED MECHANISMS OF ACTION OF ACVR1 MUTATIONS IN DIFFUSE INTRINSIC PONTINE GLIOMA | 1.1 | 0 | Citations (PDF) |
| 84 | Combined Inhibition of TGF-β Signaling and the PD-L1 Immune Checkpoint Is Differentially Effective in Tumor Models | 4.8 | 104 | Citations (PDF) |
| 85 | JNK-Dependent cJun Phosphorylation Mitigates TGFβ- and EGF-Induced Pre-Malignant Breast Cancer Cell Invasion by Suppressing AP-1-Mediated Transcriptional Responses | 4.8 | 18 | Citations (PDF) |
| 86 | A Perspective on the Development of TGF-β Inhibitors for Cancer Treatment | 4.4 | 164 | Citations (PDF) |
| 87 | Inflammation induces endothelial‐to‐mesenchymal transition and promotes vascular calcification through downregulation of BMPR2 | 5.0 | 177 | Citations (PDF) |
| 88 | TGF-β Family Signaling Pathways in Cellular Dormancy | 10.6 | 77 | Citations (PDF) |
| 89 | Bone morphogenetic protein receptor signal transduction in human disease | 5.0 | 206 | Citations (PDF) |
| 90 | TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer | 5.6 | 220 | Citations (PDF) |
| 91 | JUNB governs a feed-forward network of TGFβ signaling that aggravates breast cancer invasion | 15.7 | 102 | Citations (PDF) |
| 92 | TGF-&beta; family co-receptor function and signaling | 2.1 | 194 | Citations (PDF) |
| 93 | TGF-β Signaling in Control of Cardiovascular Function | 7.3 | 336 | Citations (PDF) |
| 94 | Bone Morphogenetic Proteins in Vascular Homeostasis and Disease | 7.3 | 140 | Citations (PDF) |
| 95 | Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis | 6.9 | 158 | Citations (PDF) |
| 96 | Epithelial–mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer? | 6.7 | 150 | Citations (PDF) |
| 97 | Bone morphogenetic protein 9 as a key regulator of liver progenitor cells in <scp>DDC</scp>‐induced cholestatic liver injury | 4.1 | 32 | Citations (PDF) |
| 98 | The therapeutic potential of targeting the endothelial-to-mesenchymal transition | 7.9 | 97 | Citations (PDF) |
| 99 | Hepatocyte-specific Smad7 deletion accelerates DEN-induced HCC via activation of STAT3 signaling in mice | 5.7 | 22 | Citations (PDF) |
| 100 | TMED10 Protein Interferes with Transforming Growth Factor (TGF)-β Signaling by Disrupting TGF-β Receptor Complex Formation | 2.2 | 30 | Citations (PDF) |
| 101 | Targeting TGF-β Signaling in Cancer | 10.6 | 898 | Citations (PDF) |
| 102 | Fluid shear stress-induced TGF-β/ALK5 signaling in renal epithelial cells is modulated by MEK1/2 | 5.6 | 35 | Citations (PDF) |
| 103 | FAF1 phosphorylation by AKT accumulates TGF-β type II receptor and drives breast cancer metastasis | 13.9 | 43 | Citations (PDF) |
| 104 | BMP type II receptor as a therapeutic target in pulmonary arterial hypertension | 5.6 | 100 | Citations (PDF) |
| 105 | SUMO-triggered ubiquitination of NR4A1 controls macrophage cell death | 13.7 | 52 | Citations (PDF) |
| 106 | BMP-9 interferes with liver regeneration and promotes liver fibrosis | 21.2 | 141 | Citations (PDF) |
| 107 | Invasive Behavior of Human Breast Cancer Cells in Embryonic Zebrafish | 0.3 | 31 | Citations (PDF) |
| 108 | Endoglin as an Important Regulator of Colorectal Cancer Invasion and Metastasis | 1.0 | 0 | Citations (PDF) |
| 109 | Disparate phospho-Smad2 levels in advanced type 2 diabetes patients with diabetic nephropathy and early experimental db/db mouse model | 2.7 | 10 | Citations (PDF) |
| 110 | Breast cancer metastasis suppressor OTUD1 deubiquitinates SMAD7 | 13.9 | 113 | Citations (PDF) |
| 111 | TGFβ1-induced SMAD2/3 and SMAD1/5 phosphorylation are both ALK5-kinase-dependent in primary chondrocytes and mediated by TAK1 kinase activity | 4.2 | 61 | Citations (PDF) |
| 112 | New function of the myostatin/activin type I receptor (ALK4) as a mediator of muscle atrophy and muscle regeneration | 0.7 | 30 | Citations (PDF) |
| 113 | Bone Morphogenetic Protein 9 Protects against Neonatal Hyperoxia-Induced Impairment of Alveolarization and Pulmonary Inflammation | 2.9 | 38 | Citations (PDF) |
| 114 | TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases | 4.5 | 326 | Citations (PDF) |
| 115 | ALK1Fc Suppresses the Human Prostate Cancer Growth in in Vitro and in Vivo Preclinical Models | 3.7 | 4 | Citations (PDF) |
| 116 | Smad6 determines BMP-regulated invasive behaviour of breast cancer cells in a zebrafish xenograft model | 3.5 | 45 | Citations (PDF) |
| 117 | Inhibition of Activin Signaling Slows Progression of Polycystic Kidney Disease | 0.4 | 45 | Citations (PDF) |
| 118 | c-Myb Enhances Breast Cancer Invasion and Metastasis through the Wnt/β-Catenin/Axin2 Pathway | 0.6 | 121 | Citations (PDF) |
| 119 | Regulation of the TGF-β pathway by deubiquitinases in cancer | 2.7 | 30 | Citations (PDF) |
| 120 | Delta-Like Ligand 4 Modulates Liver Damage by Down-Regulating Chemokine Expression | 3.4 | 30 | Citations (PDF) |
| 121 | Immunoregulation by members of the TGFβ superfamily | 56.7 | 329 | Citations (PDF) |
| 122 | Targeting tumour vasculature by inhibiting activin receptor-like kinase (ALK)1 function | 4.1 | 43 | Citations (PDF) |
| 123 | A current perspective on applications of macrocyclic‐peptide‐based high‐affinity ligands | 2.9 | 24 | Citations (PDF) |
| 124 | Expression of TGFβ-family signalling components in ageing cartilage: age-related loss of TGFβ and BMP receptors | 5.7 | 42 | Citations (PDF) |
| 125 | <scp>TGF</scp>‐β signalling and liver disease | 5.5 | 568 | Citations (PDF) |
| 126 | The rationale for targeting <scp>TGF</scp>‐β in chronic liver diseases | 3.3 | 73 | Citations (PDF) |
| 127 | Activin Receptor-like Kinase 1 Ligand Trap Reduces Microvascular Density and Improves Chemotherapy Efficiency to Various Solid Tumors | 6.9 | 50 | Citations (PDF) |
| 128 | Mutational activation of BRAF confers sensitivity to transforming growth factor beta inhibitors in human cancer cells | 1.7 | 21 | Citations (PDF) |
| 129 | Towards a cure for Fibrodysplasia ossificans progressiva | 1.8 | 10 | Citations (PDF) |
| 130 | Fibulin-4 deficiency increases TGF-β signalling in aortic smooth muscle cells due to elevated TGF-β2 levels | 3.5 | 28 | Citations (PDF) |
| 131 | A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins | 3.7 | 73 | Citations (PDF) |
| 132 | Signal Transduction: Gain of Activin Turns Muscle into Bone | 3.6 | 3 | Citations (PDF) |
| 133 | The high affinity ALK1-ligand BMP9 induces a hypertrophy-like state in chondrocytes that is antagonized by TGFβ1 | 5.7 | 31 | Citations (PDF) |
| 134 | Bone morphogenetic protein signaling in bone homeostasis | 3.6 | 203 | Citations (PDF) |
| 135 | SLUG Is Expressed in Endothelial Cells Lacking Primary Cilia to Promote Cellular Calcification | 6.3 | 47 | Citations (PDF) |
| 136 | Transforming Growth Factor β Signaling in Colorectal Cancer Cells With Microsatellite Instability Despite Biallelic Mutations in TGFBR2 | 1.0 | 59 | Citations (PDF) |
| 137 | Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models | 4.9 | 53 | Citations (PDF) |
| 138 | Clinical Utility Gene Card for: Fibrodysplasia ossificans progressiva | 3.2 | 24 | Citations (PDF) |
| 139 | Heterozygous disruption of activin receptor-like kinase 1 is associated with increased arterial pressure | 2.0 | 8 | Citations (PDF) |
| 140 | Bone morphogenetic protein 6 and oxidized low-density lipoprotein synergistically recruit osteogenic differentiation in endothelial cells | 5.7 | 89 | Citations (PDF) |
| 141 | Inhibition of TGFβ type I receptor activity facilitates liver regeneration upon acute CCl4 intoxication in mice | 6.1 | 35 | Citations (PDF) |
| 142 | Targeting BMP signalling in cardiovascular disease and anaemia | 37.5 | 228 | Citations (PDF) |
| 143 | Ter94/VCP Is a Novel Component Involved in BMP Signaling | 2.4 | 11 | Citations (PDF) |
| 144 | Nuclear receptor NR4A1 promotes breast cancer invasion and metastasis by activating TGF-β signalling | 13.9 | 179 | Citations (PDF) |
| 145 | Novel Ex Vivo Culture Method for the Study of Dupuytren's Disease: Effects of TGFβ Type 1 Receptor Modulation by Antisense Oligonucleotides | 5.6 | 25 | Citations (PDF) |
| 146 | Wild-type p53 inhibits pro-invasive properties of TGF-β3 in breast cancer, in part through regulation of EPHB2, a new TGF-β target gene | 2.4 | 24 | Citations (PDF) |
| 147 | Targeting TGF-β Signaling by Antisense Oligonucleotide-mediated Knockdown of TGF-β Type I Receptor | 5.6 | 33 | Citations (PDF) |
| 148 | Time-resolved dissection of early phosphoproteome and ensuing proteome changes in response to TGF-β | 5.5 | 42 | Citations (PDF) |
| 149 | Functionality of Endothelial Cells and Pericytes From Human Pluripotent Stem Cells Demonstrated in Cultured Vascular Plexus and Zebrafish Xenografts | 6.3 | 192 | Citations (PDF) |
| 150 | Loss of SMAD4 Alters BMP Signaling to Promote Colorectal Cancer Cell Metastasis via Activation of Rho and ROCK | 1.0 | 163 | Citations (PDF) |
| 151 | P348Impaired macrophage polarization in endoglin haplo-insufficiency leading to defective tissue repair is recovered by counter balance the TGFbeta pathway | 5.7 | 0 | Citations (PDF) |
| 152 | The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC | 5.7 | 74 | Citations (PDF) |
| 153 | ENDOGLIN Is Dispensable for Vasculogenesis, but Required for Vascular Endothelial Growth Factor-Induced Angiogenesis | 2.4 | 65 | Citations (PDF) |
| 154 | TRAF4 Promotes TGF-β Receptor Signaling and Drives Breast Cancer Metastasis | 13.4 | 220 | Citations (PDF) |
| 155 | Animal models of chronic liver diseases | 3.4 | 200 | Citations (PDF) |
| 156 | Signaling interplay between transforming growth factor-β receptor and PI3K/AKT pathways in cancer | 6.7 | 243 | Citations (PDF) |
| 157 | Preventive and therapeutic effects of Smad7 on radiation-induced oral mucositis | 39.5 | 86 | Citations (PDF) |
| 158 | Three-dimensional co-cultures of human endothelial cells and embryonic stem cell-derived pericytes inside a microfluidic device | 5.2 | 147 | Citations (PDF) |
| 159 | Snail and Slug, key regulators of TGF-β-induced EMT, are sufficient for the induction of single-cell invasion | 2.1 | 128 | Citations (PDF) |
| 160 | UBE2O negatively regulates TRAF6-mediated NF-κB activation by inhibiting TRAF6 polyubiquitination | 12.5 | 83 | Citations (PDF) |
| 161 | Deficiency for endoglin in tumor vasculature weakens the endothelial barrier to metastatic dissemination | 9.4 | 120 | Citations (PDF) |
| 162 | Transforming Growth Factor-β (TGF-β)-mediated Connective Tissue Growth Factor (CTGF) Expression in Hepatic Stellate Cells Requires Stat3 Signaling Activation | 2.2 | 175 | Citations (PDF) |
| 163 | The prognostic role of TGF-β signaling pathway in breast cancer patients | 10.2 | 87 | Citations (PDF) |
| 164 | Endoglin for tumor imaging and targeted cancer therapy | 3.9 | 40 | Citations (PDF) |
| 165 | Fine-tuning BMP7 signalling in adipogenesis by UBE2O/E2-230K-mediated monoubiquitination of SMAD6 | 7.4 | 84 | Citations (PDF) |
| 166 | Activin receptor-like kinase 1 as a target for anti-angiogenesis therapy | 4.0 | 36 | Citations (PDF) |
| 167 | Transforming growth factor-β signalling controls human breast cancer metastasis in a zebrafish xenograft model | 4.9 | 112 | Citations (PDF) |
| 168 | Antisense-Oligonucleotide Mediated Exon Skipping in Activin-Receptor-Like Kinase 2: Inhibiting the Receptor That Is Overactive in Fibrodysplasia Ossificans Progressiva | 2.4 | 36 | Citations (PDF) |
| 169 | FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension | 10.7 | 405 | Citations (PDF) |
| 170 | Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling | 2.4 | 57 | Citations (PDF) |
| 171 | Mutational Analysis of Sclerostin Shows Importance of the Flexible Loop and the Cystine-Knot for Wnt-Signaling Inhibition | 2.4 | 30 | Citations (PDF) |
| 172 | Ubiquitin-specific Protease 4 Mitigates Toll-like/Interleukin-1 Receptor Signaling and Regulates Innate Immune Activation | 2.2 | 80 | Citations (PDF) |
| 173 | Vanilloid Receptor-1 Regulates Neurogenic Inflammation in Colon and Protects Mice from Colon Cancer | 0.6 | 59 | Citations (PDF) |
| 174 | Anti-human Activin Receptor-like Kinase 1 (ALK1) Antibody Attenuates Bone Morphogenetic Protein 9 (BMP9)-induced ALK1 Signaling and Interferes with Endothelial Cell Sprouting | 2.2 | 93 | Citations (PDF) |
| 175 | Fas-associated Factor 1 Is a Scaffold Protein That Promotes β-Transducin Repeat-containing Protein (β-TrCP)-mediated β-Catenin Ubiquitination and Degradation | 2.2 | 34 | Citations (PDF) |
| 176 | Deregulated Bone Morphogenetic Protein Receptor Signaling Underlies Fibrodysplasia Ossificans Progressiva | 2.4 | 5 | Citations (PDF) |
| 177 | TGFβ Signaling in Liver Regeneration | 2.4 | 64 | Citations (PDF) |
| 178 | Tgf-β Signaling In Duchenne Muscular Dystrophy | 0.5 | 5 | Citations (PDF) |
| 179 | A Covalently Dimerized Recombinant Human Bone Morphogenetic Protein-15 Variant Identifies Bone Morphogenetic Protein Receptor Type 1B as a Key Cell Surface Receptor on Ovarian Granulosa Cells | 2.6 | 43 | Citations (PDF) |
| 180 | Key signaling nodes in mammary gland development and cancer: Smad signal integration in epithelial cell plasticity | 4.9 | 36 | Citations (PDF) |
| 181 | MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling | 34.1 | 414 | Citations (PDF) |
| 182 | USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor | 16.9 | 292 | Citations (PDF) |
| 183 | Cell‐type specific regulation of myostatin signaling | 0.7 | 63 | Citations (PDF) |
| 184 | Key role for ubiquitin protein modification in TGFβ signal transduction | 0.8 | 47 | Citations (PDF) |
| 185 | RNF12 Controls Embryonic Stem Cell Fate and Morphogenesis in Zebrafish Embryos by Targeting Smad7 for Degradation | 13.4 | 93 | Citations (PDF) |
| 186 | Wnt/β-catenin signaling changes C2C12 myoblast proliferation and differentiation by inducing Id3 expression | 2.1 | 18 | Citations (PDF) |
| 187 | LRP8 mediates Wnt/β-catenin signaling and controls osteoblast differentiation | 5.0 | 57 | Citations (PDF) |
| 188 | Shear induced collateral artery growth modulated by endoglin but not by <scp>ALK1</scp> | 4.1 | 38 | Citations (PDF) |
| 189 | The activities of Smad and Gli mediated signalling pathways in high-grade conventional osteosarcoma | 5.1 | 43 | Citations (PDF) |
| 190 | Soluble fms-like tyrosine kinase 1 and soluble endoglin are elevated circulating anti-angiogenic factors in pre-eclampsia | 1.6 | 23 | Citations (PDF) |
| 191 | TGFβ Signaling and Cardiovascular Diseases | 8.8 | 89 | Citations (PDF) |
| 192 | MicroRNA-155 Functions as a Negative Regulator of RhoA Signaling in TGF-β-induced Endothelial to Mesenchymal Transition | 1.2 | 48 | Citations (PDF) |
| 193 | TGF-β signalling and its role in cancer progression and metastasis | 7.2 | 412 | Citations (PDF) |
| 194 | BMP signaling in vascular diseases | 2.7 | 254 | Citations (PDF) |
| 195 | Nonsynonymous variants in the<i>SMAD6</i>gene predispose to congenital cardiovascular malformation | 3.9 | 128 | Citations (PDF) |
| 196 | Regulation of endothelial barrier function by TGF‐β type I receptor ALK5: Potential role of contractile mechanisms and heat shock protein 90 | 4.2 | 21 | Citations (PDF) |
| 197 | Overactive bone morphogenetic protein signaling in heterotopic ossification and Duchenne muscular dystrophy | 5.6 | 39 | Citations (PDF) |
| 198 | Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion | 6.7 | 99 | Citations (PDF) |
| 199 | Interaction with colon cancer cells hyperactivates TGF-β signaling in cancer-associated fibroblasts | 6.7 | 244 | Citations (PDF) |
| 200 | TGFβ Signaling and Cardiovascular Diseases | 8.8 | 161 | Citations (PDF) |
| 201 | Exploring anti-TGF-β therapies in cancer and fibrosis | 1.8 | 144 | Citations (PDF) |
| 202 | Temporal Smad7 Transgene Induction in Mouse Epidermis Accelerates Skin Wound Healing | 3.4 | 37 | Citations (PDF) |
| 203 | Spheroid Assay to Measure TGF-β-induced Invasion | 0.3 | 28 | Citations (PDF) |
| 204 | ALK2 mutation in a patient with Down's syndrome and a congenital heart defect | 3.2 | 40 | Citations (PDF) |
| 205 | BMP antagonists enhance myogenic differentiation and ameliorate the dystrophic phenotype in a DMD mouse model | 5.2 | 35 | Citations (PDF) |
| 206 | Activin A induces a non-fibrotic phenotype in smooth muscle cells in contrast to TGF-β | 3.2 | 12 | Citations (PDF) |
| 207 | TGF-β Signaling in Breast Cancer Cell Invasion and Bone Metastasis | 3.2 | 152 | Citations (PDF) |
| 208 | Elevated transforming growth factor β and mitogen-activated protein kinase pathways mediate fibrotic traits of Dupuytren's disease fibroblasts | 2.9 | 60 | Citations (PDF) |
| 209 | Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy | 1.8 | 42 | Citations (PDF) |
| 210 | The dynamic roles of TGF‐β in cancer | 5.0 | 353 | Citations (PDF) |
| 211 | Endoglin promotes TGF-β/Smad1 signaling in scleroderma fibroblasts | 4.2 | 72 | Citations (PDF) |
| 212 | Tgfβ/Alk5 signaling is required for shear stress induced klf2 expression in embryonic endothelial cells | 1.8 | 63 | Citations (PDF) |
| 213 | Biphasic effects of transforming growth factor β on bone morphogenetic protein–induced osteoblast differentiation | 5.0 | 84 | Citations (PDF) |
| 214 | Fas-associated factor 1 antagonizes Wnt signaling by promoting β-catenin degradation | 2.5 | 52 | Citations (PDF) |
| 215 | TGFβ Activates Mitogen- and Stress-activated Protein Kinase-1 (MSK1) to Attenuate Cell Death | 2.2 | 28 | Citations (PDF) |
| 216 | GSK3β inactivation induces apoptosis of leukemia cells by repressing the function of c-Myb | 2.5 | 54 | Citations (PDF) |
| 217 | TGF-β1/ALK5-induced monocyte migration involves PI3K and p38 pathways and is not negatively affected by diabetes mellitus | 5.7 | 39 | Citations (PDF) |
| 218 | Lack of Primary Cilia Primes Shear-Induced Endothelial-to-Mesenchymal Transition | 12.5 | 188 | Citations (PDF) |
| 219 | BMP-7 inhibits TGF-β-induced invasion of breast cancer cells through inhibition of integrin β3 expression | 4.2 | 57 | Citations (PDF) |
| 220 | Age-dependent alteration of TGF-β signalling in osteoarthritis | 2.7 | 135 | Citations (PDF) |
| 221 | Regulation of endothelial cell plasticity by TGF-β | 2.7 | 323 | Citations (PDF) |
| 222 | TGF-β in progression of liver disease | 2.7 | 692 | Citations (PDF) |
| 223 | TGF-&#946; Receptor Signaling Pathways in Angiogenesis; Emerging Targets for Anti-Angiogenesis Therapy | 2.3 | 66 | Citations (PDF) |
| 224 | ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation | 5.0 | 155 | Citations (PDF) |
| 225 | Signaling by members of the TGF-β family in vascular morphogenesis and disease | 12.3 | 378 | Citations (PDF) |
| 226 | Elevated TGFβ–Smad signalling in experimental <i>Pkd1</i> models and human patients with polycystic kidney disease | 5.0 | 93 | Citations (PDF) |
| 227 | Annexin A1 regulates TGF-β signaling and promotes metastasis formation of basal-like breast cancer cells | 7.6 | 203 | Citations (PDF) |
| 228 | Identification of a Key Residue Mediating Bone Morphogenetic Protein (BMP)-6 Resistance to Noggin Inhibition Allows for Engineered BMPs with Superior Agonist Activity | 2.2 | 113 | Citations (PDF) |
| 229 | Matrix Metalloproteinase-14 (MT1-MMP)–Mediated Endoglin Shedding Inhibits Tumor Angiogenesis | 0.6 | 247 | Citations (PDF) |
| 230 | In Situ Proximity Ligation Detection of c-Jun/AP-1 Dimers Reveals Increased Levels of c-Jun/Fra1 Complexes in Aggressive Breast Cancer Cell Lines in Vitro and in Vivo | 3.0 | 25 | Citations (PDF) |
| 231 | Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis | 9.4 | 164 | Citations (PDF) |
| 232 | Distinct Modes of Inhibition by Sclerostin on Bone Morphogenetic Protein and Wnt Signaling Pathways | 2.2 | 164 | Citations (PDF) |
| 233 | TMEPAI, a Transmembrane TGF-β-Inducible Protein, Sequesters Smad Proteins from Active Participation in TGF-β Signaling | 13.4 | 152 | Citations (PDF) |
| 234 | 5-Aminosalicylic acid inhibits TGF-β1 signalling in colorectal cancer cells | 8.8 | 22 | Citations (PDF) |
| 235 | Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanoma | 6.7 | 79 | Citations (PDF) |
| 236 | The TGF-β/Smad pathway induces breast cancer cell invasion through the up-regulation of matrix metalloproteinase 2 and 9 in a spheroid invasion model system | 2.4 | 197 | Citations (PDF) |
| 237 | VEGF and inhibitors of TGFβ type-I receptor kinase synergistically promote blood-vessel formation by inducing α5-integrin expression | 2.5 | 92 | Citations (PDF) |
| 238 | Smad3 Is a Key Nonredundant Mediator of Transforming Growth Factor β Signaling in Nme Mouse Mammary Epithelial Cells | 3.2 | 28 | Citations (PDF) |
| 239 | Dominant-Negative
<i>ALK2</i>
Allele Associates With Congenital Heart Defects | 25.2 | 100 | Citations (PDF) |
| 240 | Ski co‐repressor complexes maintain the basal repressed state of the TGF‐β target gene, <i>SMAD7</i>, via HDAC3 and PRMT5 | 1.5 | 61 | Citations (PDF) |
| 241 | Poor vessel formation in embryos from knock-in mice expressing ALK5 with L45 loop mutation defective in Smad activation | 3.3 | 20 | Citations (PDF) |
| 242 | Ionizing Radiation Shifts the PAI-1/ID-1 Balance and Activates Notch Signaling in Endothelial Cells | 1.6 | 84 | Citations (PDF) |
| 243 | Endoglin haploinsufficiency reduces radiation-induced fibrosis and telangiectasia formation in mouse kidneys | 2.0 | 41 | Citations (PDF) |
| 244 | Transforming growth factor-beta signaling and tumor angiogenesis | 6.0 | 109 | Citations (PDF) |
| 245 | Autocrine Bone Morphogenetic Protein-9 Signals through Activin Receptor-like Kinase-2/Smad1/Smad4 to Promote Ovarian Cancer Cell Proliferation | 0.6 | 115 | Citations (PDF) |
| 246 | Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis | 6.7 | 176 | Citations (PDF) |
| 247 | Shear stress modulates TGF‐beta signaling and EMT in endothelial cells | 0.7 | 0 | Citations (PDF) |
| 248 | Endoglin in angiogenesis and vascular diseases | 7.9 | 310 | Citations (PDF) |
| 249 | Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate | 6.0 | 77 | Citations (PDF) |
| 250 | ALK1 Opposes ALK5/Smad3 Signaling and Expression of Extracellular Matrix Components in Human Chondrocytes | 5.0 | 147 | Citations (PDF) |
| 251 | VE-cadherin is a critical endothelial regulator of TGF-β signalling | 7.4 | 155 | Citations (PDF) |
| 252 | Transforming Growth Factor β and Wound Healing in Human Cholesteatoma | 1.5 | 28 | Citations (PDF) |
| 253 | Transforming Growth Factor β–Induced Endothelial-to-Mesenchymal Transition: A Switch to Cardiac Fibrosis? | 7.5 | 159 | Citations (PDF) |
| 254 | The Bone Morphogenetic Protein Pathway Is Inactivated in the Majority of Sporadic Colorectal Cancers | 1.0 | 155 | Citations (PDF) |
| 255 | Two novel type II receptors mediate BMP signalling and are required to establish left–right asymmetry in zebrafish | 1.9 | 55 | Citations (PDF) |
| 256 | Osteocyte-Derived Sclerostin Inhibits Bone Formation: Its Role in Bone Morphogenetic Protein and Wnt Signaling | 3.4 | 199 | Citations (PDF) |
| 257 | L- and S-endoglin differentially modulate TGFβ1 signaling mediated by ALK1 and ALK5 in L6E9 myoblasts | 2.5 | 112 | Citations (PDF) |
| 258 | Oral administration of GW788388, an inhibitor of TGF-β type I and II receptor kinases, decreases renal fibrosis | 5.0 | 203 | Citations (PDF) |
| 259 | Role of TGF- &#946; in the Tumor Stroma | 2.5 | 21 | Citations (PDF) |
| 260 | TGF-β signaling in vascular biology and dysfunction | 12.5 | 570 | Citations (PDF) |
| 261 | Wnt but Not BMP Signaling Is Involved in the Inhibitory Action of Sclerostin on BMP-Stimulated Bone Formation | 5.0 | 252 | Citations (PDF) |
| 262 | Transforming Growth Factor-β Receptor Type I-dependent Fibrogenic Gene Program Is Mediated via Activation of Smad1 and ERK1/2 Pathways | 2.2 | 177 | Citations (PDF) |
| 263 | KLF2 Suppresses TGF-β Signaling in Endothelium Through Induction of Smad7 and Inhibition of AP-1 | 6.3 | 113 | Citations (PDF) |
| 264 | Compensatory signalling induced in the yolk sac vasculature by deletion of TGFβ receptors in mice | 2.5 | 111 | Citations (PDF) |
| 265 | Signaling by ALK5 mediates TGF-β-induced ET-1 expression in endothelial cells: a role for migration and proliferation | 2.5 | 94 | Citations (PDF) |
| 266 | BMP7, a Putative Regulator of Epithelial Homeostasis in the Human Prostate, Is a Potent Inhibitor of Prostate Cancer Bone Metastasis in Vivo | 3.4 | 194 | Citations (PDF) |
| 267 | TMEPAI, a transmembrane TGF-β-inducible protein, sequesters Smad proteins in TGF-β signaling | 0.1 | 0 | Citations (PDF) |
| 268 | SOST expression is restricted to the great arteries during embryonic and neonatal cardiovascular development | 1.8 | 43 | Citations (PDF) |
| 269 | Aberrant Bmp signaling and notochord delamination in the pathogenesis of esophageal atresia | 1.8 | 75 | Citations (PDF) |
| 270 | A rapid and sensitive bioassay to measure bone morphogenetic protein activity | 3.9 | 69 | Citations (PDF) |
| 271 | Extracellular control of TGFβ signalling in vascular development and disease | 78.9 | 754 | Citations (PDF) |
| 272 | Negative regulation of TGF-β receptor/Smad signal transduction | 3.9 | 369 | Citations (PDF) |
| 273 | TGF-β and BMP7 interactions in tumour progression and bone metastasis | 2.8 | 112 | Citations (PDF) |
| 274 | The Tumor Suppressor Smad4 Is Required for Transforming Growth Factor β–Induced Epithelial to Mesenchymal Transition and Bone Metastasis of Breast Cancer Cells | 0.6 | 360 | Citations (PDF) |
| 275 | Methylation of Smad6 by protein arginineN-methyltransferase 1 | 2.7 | 28 | Citations (PDF) |
| 276 | A Rate Equation Approach to Elucidate the Kinetics and Robustness of the TGF-β Pathway | 2.2 | 51 | Citations (PDF) |
| 277 | Bone morphogenetic protein signal transduction in bone | 2.2 | 70 | Citations (PDF) |
| 278 | Smad7-Induced β-Catenin Degradation Alters Epidermal Appendage Development | 7.8 | 155 | Citations (PDF) |
| 279 | Title is missing! | 3.9 | 50 | Citations (PDF) |
| 280 | An assay for the determination of biologically active bone morphogenetic proteins using cells transfected with an inhibitor of differentiation promoter-luciferase construct | 2.4 | 54 | Citations (PDF) |
| 281 | Id1 is a critical mediator in TGF-β-induced transdifferentiation of rat hepatic stellate cells | 10.6 | 137 | Citations (PDF) |
| 282 | Endoglin Has a Crucial Role in Blood Cell–Mediated Vascular Repair | 25.2 | 128 | Citations (PDF) |
| 283 | New mechanisms of skin innate immunity: ASK1-mediated keratinocyte differentiation regulates the expression of β-defensins, LL37, and TLR2 | 3.2 | 69 | Citations (PDF) |
| 284 | Global Analysis of Smad2/3-Dependent TGF-β Signaling in Living Mice Reveals Prominent Tissue-Specific Responses to Injury | 0.6 | 106 | Citations (PDF) |
| 285 | TGF-? receptor function in the endothelium | 5.7 | 480 | Citations (PDF) |
| 286 | SOST/sclerostin, an osteocyte-derived negative regulator of bone formation | 10.8 | 335 | Citations (PDF) |
| 287 | Transforming Growth Factor-β1 to the Bone | 25.8 | 668 | Citations (PDF) |
| 288 | Control of bone formation by osteocytes? lessons from the rare skeletal disorders sclerosteosis and van Buchem disease | 0.4 | 6 | Citations (PDF) |
| 289 | Spatio-temporal activation of Smad1 and Smad5 in vivo: monitoring transcriptional activity of Smad proteins | 2.5 | 89 | Citations (PDF) |
| 290 | Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist | 9.4 | 832 | Citations (PDF) |
| 291 | Defective paracrine signalling by TGFβ in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia | 3.1 | 142 | Citations (PDF) |
| 292 | Nerve growth factor mediates activation of the Smad pathway in PC12 cells | 0.2 | 35 | Citations (PDF) |
| 293 | Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells | 7.4 | 227 | Citations (PDF) |
| 294 | Endoglin promotes endothelial cell proliferation and TGF-β/ALK1 signal transduction | 7.4 | 630 | Citations (PDF) |
| 295 | New insights into TGF-β–Smad signalling | 6.7 | 1,126 | Citations (PDF) |
| 296 | Connective tissue growth factor expression and Smad signaling during mouse heart development and myocardial infarction | 1.8 | 100 | Citations (PDF) |
| 297 | RLP, a novel Ras-like protein, is an immediate-early transforming growth factor-β (TGF-β) target gene that negatively regulates transcriptional activity induced by TGF-β | 3.9 | 17 | Citations (PDF) |
| 298 | Gene Array Analysis of Bone Morphogenetic Protein Type I Receptor-Induced Osteoblast Differentiation | 5.0 | 55 | Citations (PDF) |
| 299 | Controlling mesenchymal stem cell differentiation by TGFβ family members | 1.3 | 163 | Citations (PDF) |
| 300 | Distribution of phosphorylated Smad2 identifies target tissues of TGFβ ligands in mouse development | 0.9 | 37 | Citations (PDF) |
| 301 | Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats | 1.0 | 360 | Citations (PDF) |
| 302 | Controlling cell fate by bone morphogenetic protein receptors | 3.5 | 183 | Citations (PDF) |
| 303 | Bone morphogenetic protein signalling in NGF-stimulated PC12 cells | 2.1 | 10 | Citations (PDF) |
| 304 | Activin Receptor-like Kinase (ALK)1 Is an Antagonistic Mediator of Lateral TGFβ/ALK5 Signaling | 13.4 | 660 | Citations (PDF) |
| 305 | Nuclear Factor YY1 Inhibits Transforming Growth Factor β- and Bone Morphogenetic Protein-Induced Cell Differentiation | 2.5 | 164 | Citations (PDF) |
| 306 | Elucidation of Smad Requirement in Transforming Growth Factor-β Type I Receptor-induced Responses | 2.2 | 192 | Citations (PDF) |
| 307 | Transforming Growth Factor-β1 (TGF-β)–induced Apoptosis of Prostate Cancer Cells Involves Smad7-dependent Activation of p38 by TGF-β-activated Kinase 1 and Mitogen-activated Protein Kinase Kinase 3 | 2.5 | 222 | Citations (PDF) |
| 308 | Transforming Growth Factor-β1 Mutations in Camurati-Engelmann Disease Lead to Increased Signaling by Altering either Activation or Secretion of the Mutant Protein | 2.2 | 108 | Citations (PDF) |
| 309 | dSmurf Selectively Degrades Decapentaplegic-activated MAD, and Its Overexpression Disrupts Imaginal Disc Development | 2.2 | 46 | Citations (PDF) |
| 310 | Smad protein and TGF-β signaling in vascular smooth muscle cells | 4.5 | 12 | Citations (PDF) |
| 311 | Growth Differentiation Factor-9 Induces Smad2 Activation and Inhibin B Production in Cultured Human Granulosa-Luteal Cells | 4.2 | 115 | Citations (PDF) |
| 312 | SIGNAL TRANSDUCTION OF BONE MORPHOGENETIC PROTEINS IN OSTEOBLAST DIFFERENTIATION | 3.4 | 92 | Citations (PDF) |
| 313 | Transient Disruption of Autocrine TGF-β Signaling Leads to Enhanced Survival and Proliferation Potential in Single Primitive Human Hemopoietic Progenitor Cells | 0.6 | 46 | Citations (PDF) |
| 314 | Stimulation of Id1 Expression by Bone Morphogenetic Protein Is Sufficient and Necessary for Bone Morphogenetic Protein–Induced Activation of Endothelial Cells | 25.2 | 286 | Citations (PDF) |
| 315 | Deficient Smad7 expression: A putative molecular defect in scleroderma | 7.6 | 232 | Citations (PDF) |
| 316 | Identification and Functional Characterization of Distinct Critically Important Bone Morphogenetic Protein-specific Response Elements in the Id1 Promoter | 2.2 | 811 | Citations (PDF) |
| 317 | Immunohistochemical Localization of Osteogenetic Protein (OP-1) and Its Receptors in Rabbit Articular Cartilage | 1.5 | 20 | Citations (PDF) |
| 318 | Activation of Bone Morphogenetic Protein/Smad Signaling in Bronchial Epithelial Cells during Airway Inflammation | 4.3 | 121 | Citations (PDF) |
| 319 | BMP Pathways Are Involved in Otic Capsule Formation and Epithelial–Mesenchymal Signaling in the Developing Chicken Inner Ear | 1.9 | 83 | Citations (PDF) |
| 320 | Engagement of activin and bone morphogenetic protein signaling pathway Smad proteins in the induction of inhibin B production in ovarian granulosa cells | 3.5 | 23 | Citations (PDF) |
| 321 | Physical and Functional Interaction between GATA-3 and Smad3 Allows TGF-β Regulation of GATA Target Genes | 3.6 | 92 | Citations (PDF) |
| 322 | Action Range of BMP Is Defined by Its N-Terminal Basic Amino Acid Core | 3.6 | 166 | Citations (PDF) |
| 323 | Regulation of cell proliferation by Smad proteins | 4.2 | 427 | Citations (PDF) |
| 324 | The FYVE domain in Smad anchor for receptor activation (SARA) is sufficient for localization of SARA in early endosomes and regulates TGF‐β/Smad signalling | 1.5 | 142 | Citations (PDF) |
| 325 | Overexpression of Smad7 results in severe pathological alterations in multiple epithelial tissues | 7.4 | 102 | Citations (PDF) |
| 326 | Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors | 7.4 | 1,023 | Citations (PDF) |
| 327 | Diffusion of Nodal Signaling Activity in the Absence of the Feedback Inhibitor Lefty2 | 7.8 | 120 | Citations (PDF) |
| 328 | Transforming growth factor β signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts | 2.7 | 187 | Citations (PDF) |
| 329 | Ectopic expression of Smad7 inhibits transforming growth factor-β responses in vascular smooth muscle cells | 4.7 | 13 | Citations (PDF) |
| 330 | Constitutive phosphorylation and nuclear localization of Smad3 are correlated with increased collagen gene transcription in activated hepatic stellate cells | 4.2 | 112 | Citations (PDF) |
| 331 | Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads | 7.4 | 168 | Citations (PDF) |
| 332 | Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice | 7.4 | 523 | Citations (PDF) |
| 333 | Transforming growth factor-β-mediated mast cell migration depends on mitogen-activated protein kinase activity | 3.6 | 55 | Citations (PDF) |
| 334 | Nodal Signaling Uses Activin and Transforming Growth Factor-β Receptor-regulated Smads | 2.2 | 107 | Citations (PDF) |
| 335 | The Orphan Receptor Serine/Threonine Kinase ALK7 Signals Arrest of Proliferation and Morphological Differentiation in a Neuronal Cell Line | 2.2 | 52 | Citations (PDF) |
| 336 | Interaction between GC Box Binding Factors and Smad Proteins Modulates Cell Lineage-specific α2(I) Collagen Gene Transcription | 2.2 | 75 | Citations (PDF) |
| 337 | Activation of the TGF- β /Activin-Smad2 Pathway during Allergic Airway Inflammation | 4.3 | 124 | Citations (PDF) |
| 338 | Apoptosis in podocytes induced by TGF-β and Smad7 | 10.7 | 259 | Citations (PDF) |
| 339 | Apoptosis in podocytes induced by TGF-β and Smad7 | 10.7 | 556 | Citations (PDF) |
| 340 | Human mast cell migration in response to members of the transforming growth factor-β family | 3.0 | 114 | Citations (PDF) |
| 341 | Expression of the inhibitory Smad7 in early mouse development and upregulation during embryonic vasculogenesis | 1.8 | 20 | Citations (PDF) |
| 342 | Signaling of transforming growth factor‐β family members through Smad proteins | 0.2 | 481 | Citations (PDF) |
| 343 | Functional consequences of tumorigenic missense mutations in the amino-terminal domain of Smad4 | 6.7 | 87 | Citations (PDF) |
| 344 | Smad7 mediates apoptosis induced by transforming growth factor β in prostatic carcinoma cells | 3.6 | 151 | Citations (PDF) |
| 345 | Signaling inputs converge on nuclear effectors in TGF-β signaling | 6.7 | 343 | Citations (PDF) |
| 346 | Efficient TGF-β Induction of the Smad7 Gene Requires Cooperation between AP-1, Sp1, and Smad Proteins on the Mouse Smad7 Promoter | 2.2 | 147 | Citations (PDF) |
| 347 | Role of Smad Proteins and Transcription Factor Sp1 in p21Waf1/Cip1 Regulation by Transforming Growth Factor-β | 2.2 | 359 | Citations (PDF) |
| 348 | Smad and AML Proteins Synergistically Confer Transforming Growth Factor β1 Responsiveness to Human Germ-line IgA Genes | 2.2 | 139 | Citations (PDF) |
| 349 | The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling | 15.7 | 103 | Citations (PDF) |
| 350 | Activin receptor-like kinase 1 modulates transforming growth factor-β1 signaling in the regulation of angiogenesis | 7.6 | 821 | Citations (PDF) |
| 351 | Hedgehog Creates a Gradient of DPP Activity in Drosophila Wing Imaginal Discs | 13.4 | 403 | Citations (PDF) |
| 352 | Correlation between ALK-6 (BMPR-IB) Distribution and Responsiveness to Osteogenic Protein-1 (BMP-7) in Embryonic Mouse Bone Rudiments | 1.8 | 21 | Citations (PDF) |
| 353 | TGF-β signaling by Smad proteins | 7.1 | 425 | Citations (PDF) |
| 354 | Specificity, diversity, and regulation in TGF‐β superfamily signaling | 0.7 | 734 | Citations (PDF) |
| 355 | Expression of TGF-beta related Smad proteins in human epithelial skin tumors. | 4.0 | 17 | Citations (PDF) |
| 356 | Expression of Transforming Growth Factor-β1, Activin A, and Their Receptors in Thyroid Follicle Cells: Negative Regulation of Thyrocyte Growth and Function1 | 2.6 | 55 | Citations (PDF) |
| 357 | Eccrine Sweat Glands: Expression of Transforming Growth Factor-beta and Bone Morphogenetic Protein Type I Receptors and Their Intracellular Signalling Smad Proteins | 1.9 | 5 | Citations (PDF) |
| 358 | Differential Inhibition of Smad6 and Smad7 on Bone Morphogenetic Protein- and Activin-mediated Growth Arrest and Apoptosis in B Cells | 2.2 | 206 | Citations (PDF) |
| 359 | Localization of Smads, the TGF-β Family Intracellular Signaling Components During Endochondral Ossification | 5.0 | 145 | Citations (PDF) |
| 360 | Chromosomal localization of three human genes encoding bone morphogenetic protein receptors | 2.3 | 14 | Citations (PDF) |
| 361 | Functional antagonism between activin and osteogenic protein-1 in human embryonal carcinoma cells 1999, 180, 141-149 | | 43 | Citations (PDF) |
| 362 | Molecular analyses of the 15q and 18qSMAD genes in pancreatic cancer 1999, 24, 62-71 | | 54 | Citations (PDF) |
| 363 | Expression of transforming-growth-factor (TGF)-? receptors and Smad proteins in glioblastoma cell lines with distinct responses to TGF-?1 1999, 80, 756-763 | | 74 | Citations (PDF) |
| 364 | Expression of Smad proteins in human colorectal cancer | 4.5 | 100 | Citations (PDF) |
| 365 | Lack of responsiveness to TGF-β1 in a thyroid carcinoma cell line with functional type I and type II TGF-β receptors and Smad proteins, suggests a novel mechanism for TGF-β insensitivity in carcinoma cells | 3.5 | 26 | Citations (PDF) |
| 366 | Xenopus Smad4β Is the Co-Smad Component of Developmentally Regulated Transcription Factor Complexes Responsible for Induction of Early Mesodermal Genes | 1.9 | 89 | Citations (PDF) |
| 367 | Expression of Transforming Growth Factor- 1, Activin A, and Their Receptors in Thyroid Follicle Cells: Negative Regulation of Thyrocyte Growth and Function | 2.6 | 15 | Citations (PDF) |
| 368 | Cartilage-Derived Morphogenetic Proteins and Osteogenic Protein-1 Differentially Regulate Osteogenesis | 5.0 | 146 | Citations (PDF) |
| 369 | Direct binding of Smad3 and Smad4 to critical TGFbeta -inducible elements in the promoter of human plasminogen activator inhibitor-type 1gene | 7.4 | 1,692 | Citations (PDF) |
| 370 | Intracellular signaling of osteogenic protein-1 through Smad5 activation 1998, 177, 355-363 | | 74 | Citations (PDF) |
| 371 | Immunohistochemical detection of activin A, follistatin, and activin receptors during fracture healing in the rat | 2.5 | 32 | Citations (PDF) |
| 372 | Identification of receptors and Smad proteins involved in activin signalling in a human epidermal keratinocyte cell line | 1.5 | 70 | Citations (PDF) |
| 373 | Distinct and Overlapping Patterns of Localization of Bone Morphogenetic Protein (BMP) Family Members and a BMP Type II Receptor During Fracture Healing in Rats | 3.6 | 266 | Citations (PDF) |
| 374 | The L45 loop in type I receptors for TGF-β family members is a critical determinant in specifying Smad isoform activation | 2.7 | 360 | Citations (PDF) |
| 375 | Induction of Inhibitory Smad6 and Smad7 mRNA by TGF-β Family Members | 2.1 | 336 | Citations (PDF) |
| 376 | Cloning and Characterization of p70S6KβDefines a Novel Family of p70 S6 Kinases | 2.1 | 51 | Citations (PDF) |
| 377 | Smad7 Is an Activin-inducible Inhibitor of Activin-induced Growth Arrest and Apoptosis in Mouse B Cells | 2.2 | 120 | Citations (PDF) |
| 378 | Identification and Functional Characterization of a Smad Binding Element (SBE) in the JunB Promoter That Acts as a Transforming Growth Factor-β, Activin, and Bone Morphogenetic Protein-inducible Enhancer | 2.2 | 530 | Citations (PDF) |
| 379 | Transforming Growth Factor β1 Induces Nuclear Export of Inhibitory Smad7 | 2.2 | 220 | Citations (PDF) |
| 380 | Physical and Functional Interaction of Murine and Xenopus Smad7 with Bone Morphogenetic Protein Receptors and Transforming Growth Factor-β Receptors | 2.2 | 146 | Citations (PDF) |
| 381 | Phosphorylation of Ser465 and Ser467 in the C Terminus of Smad2 Mediates Interaction with Smad4 and Is Required for Transforming Growth Factor-β Signaling | 2.2 | 359 | Citations (PDF) |
| 382 | Transforming Growth Factor (TGF-β)-specific Signaling by Chimeric TGF-β Type II Receptor with Intracellular Domain of Activin Type IIB Receptor | 2.2 | 32 | Citations (PDF) |
| 383 | Identification of Smad2, a Human Mad-related Protein in the Transforming Growth Factor β Signaling Pathway | 2.2 | 155 | Citations (PDF) |
| 384 | Latent transforming growth factor-<i>β</i> complex in Chinese hamster ovary cells contains the multifunctional cysteine-rich fibroblast growth factor receptor, also termed E-selectin-ligand or MG-160 | 3.9 | 28 | Citations (PDF) |
| 385 | Expression and localization of bone morphogenetic proteins (BMPs) and BMP receptors in ossification of the ligamentum flavum | 3.6 | 102 | Citations (PDF) |
| 386 | DPC4 (SMAD4) mediates transforming growth factor-β1 (TGF-β1) induced growth inhibition and transcriptional response in breast tumour cells | 6.7 | 132 | Citations (PDF) |
| 387 | TGF-β signalling from cell membrane to nucleus through SMAD proteins | 38.7 | 3,617 | Citations (PDF) |
| 388 | TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4 | 7.4 | 996 | Citations (PDF) |
| 389 | Orthotopic ossification of the spinal ligaments of zucker fatty rats: A possible animal model for ossification of the human posterior longitudinal ligament | 2.5 | 23 | Citations (PDF) |
| 390 | Characterization of a 60-kDa cell surface-associated transforming growth factor-β binding protein that can interfere with transforming growth factor-β receptor binding | 4.2 | 24 | Citations (PDF) |
| 391 | Bone morphogenetic protein receptors | 3.6 | 211 | Citations (PDF) |
| 392 | Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors | 3.5 | 186 | Citations (PDF) |
| 393 | Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors | 3.9 | 254 | Citations (PDF) |
| 394 | Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma tumours | 5.7 | 33 | Citations (PDF) |
| 395 | A Novel Type I Receptor Serine-Threonine Kinase Predominantly Expressed in the Adult Central Nervous System | 2.2 | 70 | Citations (PDF) |
| 396 | Cloning and characterization of a human type II receptor for bone morphogenetic proteins. | 7.6 | 515 | Citations (PDF) |
| 397 | A Rat Pituitary Tumor Cell Line (GH3
) Expresses Type I and Type II Receptors and Other Cell Surface Binding Protein(s) for Transforming Growth Factor-
β | 2.2 | 22 | Citations (PDF) |
| 398 | Efficient Association of an Amino-terminally Extended Form of Human Latent Transforming Growth Factor-β Binding Protein with the Extracellular Matrix | 2.2 | 81 | Citations (PDF) |
| 399 | Expression of type I and type IB receptors for activin in midgestation mouse embryos suggests distinct functions in organogenesis | 2.6 | 111 | Citations (PDF) |
| 400 | Distinct spatial and temporal expression patterns of two type I receptors for bone morphogenetic proteins during mouse embryogenesis | 2.6 | 81 | Citations (PDF) |
| 401 | Serine/threonine kinase receptors | 1.2 | 72 | Citations (PDF) |
| 402 | Characterization of in Vivo Phosphorylation of Activin Type II Receptor | 2.1 | 19 | Citations (PDF) |
| 403 | Regulation of the levels of three transforming growth factor β mRNAs by estrogen and their effects on the proliferation of human breast cancer cells | 3.5 | 51 | Citations (PDF) |
| 404 | Cloning of a TGF$beta; type I receptor that forms a heteromeric complex with the TGF$beta; type II receptor | 34.1 | 771 | Citations (PDF) |
| 405 | Molecular Characterization of Transforming Growth Factor Type ?3 | 4.1 | 34 | Citations (PDF) |
| 406 | Distinct transforming growth factor-beta (TGF-beta) receptor subsets as determinants of cellular responsiveness to three TGF-beta isoforms | 2.2 | 313 | Citations (PDF) |
| 407 | Growth Factors For Wound Healing | 32.2 | 64 | Citations (PDF) |
| 408 | Identification of another member of the transforming growth factor type beta gene family. | 7.6 | 295 | Citations (PDF) |
| 409 | Genomic characterization of the human DNA excision repair geneERCC-1 | 15.7 | 73 | Citations (PDF) |
